118 related articles for article (PubMed ID: 12270157)
21. 3Beta-sulfamate derivatives of C19 and C21 steroids bearing a t-butylbenzyl or a benzyl group: synthesis and evaluation as non-estrogenic and non-androgenic steroid sulfatase inhibitors.
Ciobanu LC; Boivin RP; Luu-The V; Poirier D
J Enzyme Inhib Med Chem; 2003 Feb; 18(1):15-26. PubMed ID: 12751816
[TBL] [Abstract][Full Text] [Related]
22. New inhibitors of fungal 17beta-hydroxysteroid dehydrogenase based on the [1,5]-benzodiazepine scaffold.
Zivec M; Sova M; Brunskole M; Lenarsic R; Rizner TL; Gobec S
J Enzyme Inhib Med Chem; 2007 Feb; 22(1):29-36. PubMed ID: 17373544
[TBL] [Abstract][Full Text] [Related]
23. Solid-phase synthesis of hydroxysteroid derivatives using the diethylsilyloxy linker.
Maltais R; Tremblay MR; Poirier D
J Comb Chem; 2000; 2(6):604-14. PubMed ID: 11126290
[TBL] [Abstract][Full Text] [Related]
24. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozymes I and II and transmembrane, tumor-associated isozyme IX with sulfamates including EMATE also acting as steroid sulfatase inhibitors.
Winum JY; Vullo D; Casini A; Montero JL; Scozzafava A; Supuran CT
J Med Chem; 2003 May; 46(11):2197-204. PubMed ID: 12747791
[TBL] [Abstract][Full Text] [Related]
25. 3,17-disubstituted 2-alkylestra-1,3,5(10)-trien-3-ol derivatives: synthesis, in vitro and in vivo anticancer activity.
Bubert C; Leese MP; Mahon MF; Ferrandis E; Regis-Lydi S; Kasprzyk PG; Newman SP; Ho YT; Purohit A; Reed MJ; Potter BV
J Med Chem; 2007 Sep; 50(18):4431-43. PubMed ID: 17696419
[TBL] [Abstract][Full Text] [Related]
26. First report of the investigation into the importance of pK(a) in the inhibition of estrone sulfatase by sulfamate containing compounds.
Ahmed S; James K; Patel CK
Biochem Biophys Res Commun; 2000 Jun; 272(2):583-5. PubMed ID: 10833455
[TBL] [Abstract][Full Text] [Related]
27. Chemical synthesis and biological activities of 16alpha-derivatives of 5alpha-androstane-3alpha,17beta-diol as antiandrogens.
Roy J; Breton R; Martel C; Labrie F; Poirier D
Bioorg Med Chem; 2007 Apr; 15(8):3003-18. PubMed ID: 17336533
[TBL] [Abstract][Full Text] [Related]
28. Identification of fused 16β,17β-oxazinone-estradiol derivatives as a new family of non-estrogenic 17β-hydroxysteroid dehydrogenase type 1 inhibitors.
Maltais R; Trottier A; Delhomme A; Barbeau X; Lagüe P; Poirier D
Eur J Med Chem; 2015 Mar; 93():470-80. PubMed ID: 25728028
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and some properties of sulfate esters and sulfamates of iodothyronines.
Mol JA; Visser TJ
Endocrinology; 1985 Jul; 117(1):1-7. PubMed ID: 4006859
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and optimization of a new family of type 3 17 beta-hydroxysteroid dehydrogenase inhibitors by parallel liquid-phase chemistry.
Maltais R; Luu-The V; Poirier D
J Med Chem; 2002 Jan; 45(3):640-53. PubMed ID: 11806715
[TBL] [Abstract][Full Text] [Related]
31. Dydrogesterone (Duphaston) and its 20-dihydro-derivative as selective estrogen enzyme modulators in human breast cancer cell lines. Effect on sulfatase and on 17beta-hydroxysteroid dehydrogenase (17beta-HSD) activity.
Chetrite GS; Thole HH; Philippe JC; Pasqualini JR
Anticancer Res; 2004; 24(3a):1433-8. PubMed ID: 15274306
[TBL] [Abstract][Full Text] [Related]
32. Inhibitors of type 1 17beta-hydroxysteroid dehydrogenase with reduced estrogenic activity: modifications of the positions 3 and 6 of estradiol.
Tremblay MR; Boivin RP; Luu-The V; Poirier D
J Enzyme Inhib Med Chem; 2005 Apr; 20(2):153-63. PubMed ID: 15968820
[TBL] [Abstract][Full Text] [Related]
33. Structure-activity relationships of C-17-substituted estratriene-3-O-sulfamates as anticancer agents.
Jourdan F; Leese MP; Dohle W; Ferrandis E; Newman SP; Chander S; Purohit A; Potter BV
J Med Chem; 2011 Jul; 54(13):4863-79. PubMed ID: 21604672
[TBL] [Abstract][Full Text] [Related]
34. Synthesis and evaluation of general mechanism-based inhibitors of sulfatases based on (difluoro)methyl phenyl sulfate and cyclic phenyl sulfamate motifs.
Hanson SR; Whalen LJ; Wong CH
Bioorg Med Chem; 2006 Dec; 14(24):8386-95. PubMed ID: 17045481
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological behavior of a boronated analogue of the antiestrogen U 23,469-M.
Wellmann F; Abraham R; Müller R; Gabel D
Z Naturforsch C J Biosci; 1991; 46(3-4):252-6. PubMed ID: 1878109
[TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and biological evaluation of bis(hydroxyphenyl) azoles as potent and selective non-steroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) for the treatment of estrogen-dependent diseases.
Bey E; Marchais-Oberwinkler S; Kruchten P; Frotscher M; Werth R; Oster A; Algül O; Neugebauer A; Hartmann RW
Bioorg Med Chem; 2008 Jun; 16(12):6423-35. PubMed ID: 18514529
[TBL] [Abstract][Full Text] [Related]
37. 2-Substituted 4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.
Nussbaumer P; Lehr P; Billich A
J Med Chem; 2002 Sep; 45(19):4310-20. PubMed ID: 12213072
[TBL] [Abstract][Full Text] [Related]
38. The role of 17beta-hydroxysteroid dehydrogenases in modulating the activity of 2-methoxyestradiol in breast cancer cells.
Newman SP; Ireson CR; Tutill HJ; Day JM; Parsons MF; Leese MP; Potter BV; Reed MJ; Purohit A
Cancer Res; 2006 Jan; 66(1):324-30. PubMed ID: 16397246
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of estrogen sulfamates: compounds with a novel endocrinological profile.
Schwarz S; Thieme I; Richter M; Undeutsch B; Henkel H; Elger W
Steroids; 1996 Dec; 61(12):710-7. PubMed ID: 8987140
[TBL] [Abstract][Full Text] [Related]
40. Estradiol-adenosine hybrid compounds designed to inhibit type 1 17beta-hydroxysteroid dehydrogenase.
Poirier D; Boivin RP; Tremblay MR; Bérubé M; Qiu W; Lin SX
J Med Chem; 2005 Dec; 48(26):8134-47. PubMed ID: 16366595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]